Quantitative Analysis of Muscarinic Acetylcholine Receptor Homo- and Heterodimerization in Live Cells
暂无分享,去创建一个
[1] J. W. Wells,et al. Effects of adenyl nucleotides and carbachol on cooperative interactions among G proteins. , 1992, Biochemistry.
[2] L. Potter,et al. Evidence of paired M2 muscarinic receptors. , 1991, Molecular pharmacology.
[3] J. Nathans,et al. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains , 2001, Nature.
[4] Xiaochun Sun,et al. Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer , 2005, Molecular Pharmacology.
[5] N. Nathanson,et al. Identification of a Region Required for Subtype-specific Agonist-induced Sequestration of the m2 Muscarinic Acetylcholine Receptor (*) , 1996, The Journal of Biological Chemistry.
[6] G. Milligan,et al. High-affinity interactions between human α1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the α1L-adrenoceptor , 2004 .
[7] S. Yamada,et al. Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice. , 2005, Brain research. Molecular brain research.
[8] Jean-François Mercier,et al. Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.
[9] K. Eidne,et al. G-protein coupled receptor oligomerization in neuroendocrine pathways , 2003, Frontiers in Neuroendocrinology.
[10] W. Sadee,et al. Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. , 1992, The Journal of biological chemistry.
[11] G. Demontis,et al. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.
[12] J. W. Wells,et al. Monomers and oligomers of the M2 muscarinic cholinergic receptor purified from Sf9 cells. , 2003, Biochemistry.
[13] R. Ostrom,et al. M2 muscarinic receptor inhibition of agonist-induced cyclic adenosine monophosphate accumulation and relaxation in the guinea pig ileum. , 1997, The Journal of pharmacology and experimental therapeutics.
[14] Christopher A Reynolds,et al. Dimerization and Domain Swapping in G-Protein-Coupled Receptors: A Computational Study , 2000, Neuropsychopharmacology.
[15] C. Johnson,et al. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] F. Giorgi,et al. Paired Activation of Two Components within Muscarinic M3 Receptor Dimers Is Required for Recruitment of β-Arrestin-1 to the Plasma Membrane* , 2005, Journal of Biological Chemistry.
[17] T. Maniatis,et al. Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector system , 1981, Cell.
[18] N. Nathanson,et al. Identification of a Basolateral Sorting Signal for the M3 Muscarinic Acetylcholine Receptor in Madin-Darby Canine Kidney Cells* , 2001, The Journal of Biological Chemistry.
[19] N. Nathanson,et al. Differential role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor. , 1994, The Journal of biological chemistry.
[20] C. Brumwell,et al. Isolation and characterization of monoclonal antibodies specific for the cardiac muscarinic acetylcholine receptor. , 1987, Biochemistry.
[21] P. Fossier,et al. Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.
[22] J. Wess,et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. W. Wells,et al. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. , 1997, Biochemistry.
[24] N. Nathanson,et al. In vivo regulation of muscarinic acetylcholine receptor number and function in embryonic chick heart. , 1981, The Journal of biological chemistry.
[25] Michel Bouvier,et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.
[26] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[27] Y. Furukawa,et al. Heterogeneous Distribution Of β‐Adrenoceptors and Muscarinic Receptors In The Sinoatrial Node And Right Atrium Of The Dog , 2002, Clinical and experimental pharmacology & physiology.
[28] Fu-Yue Zeng,et al. Molecular Aspects of Muscarinic Receptor Dimerization , 2000, Neuropsychopharmacology.
[29] M. Bouvier,et al. Hetero-oligomerization between β2- and β3-Adrenergic Receptors Generates a β-Adrenergic Signaling Unit with Distinct Functional Properties* , 2004, Journal of Biological Chemistry.
[30] P. Delagrange,et al. Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers , 2004, Molecular Pharmacology.
[31] K. Kameyama,et al. Internalization and Down-regulation of Human Muscarinic Acetylcholine Receptor m2 Subtypes , 1998, The Journal of Biological Chemistry.
[32] Michel Bouvier,et al. Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.
[33] L. Stryer,et al. The dimeric nature of the gramicidin A transmembrane channel: conductance and fluorescence energy transfer studies of hybrid channels. , 1977, Journal of molecular biology.
[34] J. W. Wells,et al. Oligomeric potential of the M2 muscarinic cholinergic receptor , 2004, Journal of neurochemistry.
[35] N. Nathanson,et al. Synergistic Regulation of m2 Muscarinic Acetylcholine Receptor Desensitization and Sequestration by G Protein-coupled Receptor Kinase-2 and β-Arrestin-1* , 1997, The Journal of Biological Chemistry.
[36] J. Wess,et al. Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.
[37] A. G. Roseberry,et al. Trafficking of M2 Muscarinic Acetylcholine Receptors* , 1999, The Journal of Biological Chemistry.
[38] R. Moon,et al. Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization , 2004, Nature Cell Biology.
[39] N. Nathanson,et al. Subtype‐specific regulation of the expression and function of muscarinic acetylcholine receptors in embryonic chicken retinal cells , 2002, Journal of neurochemistry.
[40] M. Schimerlik,et al. A kinetic model for oxotremorine M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.
[41] N. Nathanson,et al. Multiple Topological Domains Mediate Subtype-specific Internalization of the M2 Muscarinic Acetylcholine Receptor* , 2000, The Journal of Biological Chemistry.
[42] K. Fuxe,et al. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.
[43] Gerda E Breitwieser,et al. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. , 2004, Circulation research.
[44] F. Ehlert,et al. Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination. , 2003, Biochemical pharmacology.
[45] M. Scarselli,et al. The Paired Activation of the Two Components of the Muscarinic M3 Receptor Dimer Is Required for Induction of ERK1/2 Phosphorylation* , 2004, Journal of Biological Chemistry.
[46] N. Nathanson,et al. Tissue-specific Regulation of Muscarinic Acetylcholine Receptor Expression during Embryonic Development (*) , 1995, The Journal of Biological Chemistry.